MACROGENICS INC — Director's Dealing 2018

Mar 6, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2018-03-02

Reporting Person: Wigginton Jon Marc (Sr VP, Clinical Dev. & CMO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-02	Employee stock option (right to buy)	$28.94	A	70000	Acquired	2028-03-02	Common Stock (70000.0)	Direct

Footnotes

F1: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter.